Literature DB >> 20817290

Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment.

Fu-Min Fang1, Wen-Ling Tsai, Tsair-Fwu Lee, Kuan-Cho Liao, Hui-Chun Chen, Hsuan-Chih Hsu.   

Abstract

PURPOSE: The study analyzed the prognostic factors of quality of life (QoL) for patients with nasopharyngeal carcinoma (NPC) after treatment, with focusing on the therapeutic benefits of the technological advances in radiotherapy (RT).
MATERIALS AND METHODS: A cross-sectional investigation was conducted to assess the QoL of 356 NPC patients with cancer-free survival of more than 2 years. Among them, 106 patients were treated by two-dimensional RT (2DRT), 108 by 2DRT plus three-dimensional conformal RT (3DCRT) boost, 58 by 3DCRT alone, and 84 by intensity-modulated RT (IMRT). The QoL was assessed by the EORTC QLQ-C30 questionnaire and QLQ-H&N35 module. The clinical difference of QoL scores between groups was calculated using Cohen's D coefficient.
RESULTS: We found NPC survivors who had a higher education level or annual family income and who had received more advanced RT treatments had better QoL outcomes. Compared with 2DRT, the impact of 3DCRT was small on most scales and moderate (Cohen's D: 0.53-0.67) on emotional functioning, pain, and mouth opening; the impact of IMRT was moderate on nine scales and large (Cohen's D: 0.80-0.88) on swallowing, social eating, teeth, and mouth opening.
CONCLUSIONS: In addition to socioeconomic levels, advances in RT technique played a significant role in improving QoL of NPC patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20817290     DOI: 10.1016/j.radonc.2010.05.022

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

1.  Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.

Authors:  Luciana Lastrucci; Silvia Bertocci; Vittorio Bini; Simona Borghesi; Roberta De Majo; Andrea Rampini; Paola Pernici; Pietro Giovanni Gennari
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

2.  Functional swallowing outcomes in nasopharyngeal cancer treated with IMRT at 6 to 42 months post-radiotherapy.

Authors:  Margaret Patterson; Rowena Brain; Ronald Chin; David Veivers; Michael Back; Andrew Wignall; Thomas Eade
Journal:  Dysphagia       Date:  2014-08-13       Impact factor: 3.438

3.  Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.

Authors:  Kimberly R Porter; Usha Menon; Nicholas A Vick; John L Villano; Michael L Berbaum; Faith G Davis
Journal:  Support Care Cancer       Date:  2014-01-03       Impact factor: 3.603

4.  Predictors of pain among patients with head and neck cancer.

Authors:  Andrew G Shuman; Jeffrey E Terrell; Emily Light; Gregory T Wolf; Carol R Bradford; Douglas Chepeha; Yunyun Jiang; Scott McLean; Tamer A Ghanem; Sonia A Duffy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-12-01

5.  Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.

Authors:  Bing-Qing Xu; Zi-Wei Tu; Ya-Lan Tao; Zhi-Gang Liu; Xiao-Hui Li; Wei Yi; Chang-Bing Jiang; Yun-Fei Xia
Journal:  Chin J Cancer       Date:  2016-04-07

Review 6.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

7.  Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hung-Yu Wang; Hsuan-Chih Hsu; PaoShu Chang; Wen-Cheng Chen
Journal:  BMC Cancer       Date:  2012-12-04       Impact factor: 4.430

8.  Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.

Authors:  Tsair-Fwu Lee; Ming-Hsiang Liou; Hui-Min Ting; Liyun Chang; Hsiao-Yi Lee; Stephen Wan Leung; Chih-Jen Huang; Pei-Ju Chao
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

9.  Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Liyun Chang; Yu-Jie Huang; Jia-Ming Wu; Hung-Yu Wang; Mong-Fong Horng; Chun-Ming Chang; Jen-Hong Lan; Ya-Yu Huang; Fu-Min Fang; Stephen Wan Leung
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with different RT technologies.

Authors:  L Jang-Chun; H Jing-Min; J Yee-Min; L Dai-Wei; C Chang-Ming; L Chun-Shu; H Wen-Yen; S Yu-Fu; L Kuen-Tze; F Chao-Yueh; L Cheng-Hsiang; C Hsing-Lung
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-08       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.